ArticleCancer research communications2023
An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers.
Boris Guyot et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.